Kura Oncology initiated with an Outperform at LifeSci Capital
The Fly

Kura Oncology initiated with an Outperform at LifeSci Capital

LifeSci Capital initiated coverage of Kura Oncology (KURA) with an Outperform rating and $30 price target

Don't Miss out on Research Tools:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App